GMAB · Genmab A/S
AI read · Neutral
The AI's read
The announcement shows that Genmab is continuing to study epcoritamab across several blood cancers and treatment settings. But it shares no study results, so readers cannot tell whether the drug is helping patients. The planned presentations alone do not change the company's outlook.